|
[1]
|
Singh, D., Agusti, A., Anzueto, A., et al. (2019) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: The GOLD Science Committee Report 2019. European Respiratory Journal, 53, Article ID: 1900164. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Wang, C., Xu, J., Yang, L., et al. (2018) Prevalence and Risk Factors Of Chronic Obstructive Pulmonary Disease in China (the China Pulmonary Health [CPH] Study): A National Cross-Sectional Study. The Lancet, 391, 1706-1717. [Google Scholar] [CrossRef]
|
|
[3]
|
Mathers, C.D. and Loncar, D. (2006) Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLOS Medicine, 3, e442. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Hayes, D., Daniels, C.J., Mansour, H.M., et al. (2013) Right Heart Catheterization Measuring Central Hemodynamics in Cystic Fibrosis during Exercise. Respiratory Medicine, 107, 1365-1369. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Poor, H.D., Girgis, R. and Studer, S.M. (2012) World Health Organization Group III Pulmonary Hypertension. Progress in Cardiovascular Diseases, 55, 119-127. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Sommer, N., Dietrich, A., Schermuly, R.T., et al. (2008) Regulation of Hypoxic Pulmonary Vasoconstriction: Basic Mechanisms. European Respiratory Journal, 32, 1639-1651. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Blanco, I., Tura-Ceide, O., Peinado, V.I., et al. (2020) Updated Perspectives on Pulmonary Hypertension in COPD. International Journal of Chronic Obstructive Pulmonary Disease, 15, 1315-1324. [Google Scholar] [CrossRef]
|
|
[8]
|
Humbert, M., Guignabert, C., Bonnet, S., et al. (2019) Pathology and Pathobiology of Pulmonary Hypertension: State of the Art and Research Perspectives. European Respiratory Journal, 53, Article ID: 1801887. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Zuo, H., Xie, X., Peng, J., et al. (2019) Predictive Value of Novel Inflammation-Based Biomarkers for Pulmonary Hypertension in the Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Analytical Cellular Pathology (Amsterdam), 2019, Article ID: 5189165. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Nakayama, S., Chubachi, S., Sakurai, K., et al. (2020) Characteristics of Chronic Obstructive Pulmonary Disease Patients with Pulmonary Hypertension Assessed by Echocardiography in a Three-Year Observational Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease, 15, 487-499. [Google Scholar] [CrossRef]
|
|
[11]
|
Gredic, M., Blanco, I., Kovacs, G., et al. (2021) Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease. British Journal of Pharmacology, 178, 132-151. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Sincer, I., Zorlu, A., Yilmaz, M.B., et al. (2012) Relationship between Red Cell Distribution Width and Right Ventricular Dysfunction in Patients with Chronic Obstructive Pulmonary Disease. Heart Lung, 41, 238-243. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
隋晓伟, 孙丽蓉. 红细胞分布宽度与慢性阻塞性肺疾病合并肺动脉高压的相关性[J]. 包头医学院学报, 2017, 33(12): 22-23. [Google Scholar] [CrossRef]
|
|
[14]
|
Casserly, B. and Klinger, J.R. (2009) Brain Natriuretic Peptide in Pulmonary Arterial Hypertension: Biomarker and Potential Therapeutic Agent. Drug Design, Development and Therapy, 3, 269-287. [Google Scholar] [CrossRef]
|
|
[15]
|
Chang, W.T., Shih, J.Y., Hong, C.S., et al. (2021) Right Ventricular Expression of NT-proBNP Adds Predictive Value to REVEAL Score in Patients with Pulmonary Arterial Hypertension. ESC Heart Failure, 8, 3082-3092. [Google Scholar] [CrossRef] [PubMed]
|